Morphic Therapeutic

company

About

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.

  • 51 - 100

Details

Last Funding Type
Seed
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$134.50M
Morphic Therapeutic has raised a total of $134.50M in funding over 2 rounds. Their latest funding was raised on Sep 25, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 25, 2018 Series B $80M 1 Detail
Jun 30, 2016 Series A $51.50M 1 Detail
Jan 1, 2016 Seed $3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Morphic Therapeutic is funded by 1 investors. Schrödinger are the most recent investors.
Investor Name Lead Investor Funding Round
Schrödinger Series B